The prevalence of TNFα-induced necrosis over apoptosis is determined by TAK1-RIP1 interplay

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Arslan, Seda Çöl ^a   Scheidereit, Claus ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR PROTEIN; NUCLEAR RECEPTOR COACTIVATOR 2; REACTIVE OXYGEN METABOLITE; RECEPTOR INTERACTING PROTEIN 3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; CASPASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; RALBP1 PROTEIN, MOUSE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BIOACCUMULATION; CELL DEATH; CELL FUNCTION; CELL PROTECTION; CELL STIMULATION; COMPLEX FORMATION; CONTROLLED STUDY; DISSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR BINDING; TRANSCRIPTION REGULATION; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ENZYMOLOGY; GENE INACTIVATION; GENETICS; HUMAN; METABOLISM; NECROSIS; PATHOLOGY; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE; UBIQUITINATION;

ANIMALS; APOPTOSIS; CASPASES; CELL LINE, TUMOR; GENE KNOCKOUT TECHNIQUES; GTPASE-ACTIVATING PROTEINS; HUMANS; MAP KINASE KINASE KINASES; MICE; NECROSIS; NF-KAPPA B; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITINATION;

EID: 80053927315     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026069     Document Type: Article

References (27)

1. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G, (2010) Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11: 700-714.
2. Wajant H, Scheurich P, (2011) TNFR1-induced activation of the classical NF-kappaB pathway. FEBS J 278: 862-876.
3. Vandenabeele P, Declercq W, Van Herreweghe F, Vanden Berghe T, (2010) The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci Signal 3: re4.
4. Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, et al. (1999) The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 189: 1839-1845.
5. Rudolph D, Yeh WC, Wakeham A, Rudolph B, Nallainathan D, et al. (2000) Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev 14: 854-862.
6. Varfolomeev EE, Ashkenazi A, (2004) Tumor necrosis factor: an apoptosis JuNKie? Cell 116: 491-497.
7. Wang L, Du F, Wang X, (2008) TNF-alpha induces two distinct caspase-8 activation pathways. Cell 133: 693-703.
8. Cho YS, Challa S, Moquin D, Genga R, Ray TD, et al. (2009) Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137: 1112-1123.
9. He S, Wang L, Miao L, Wang T, Du F, et al. (2009) Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137: 1100-1111.
10. Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, et al. (2009) RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325: 332-336.
11. Geserick P, Hupe M, Moulin M, Wong WW, Feoktistova M, et al. (2009) Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. J Cell Biol 187: 1037-1054.
12. Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, et al. (2011) Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471: 363-367.
13. Yu JW, Shi Y, (2008) FLIP and the death effector domain family. Oncogene 27: 6216-6227.
14. Bettermann K, Vucur M, Haybaeck J, Koppe C, Janssen J, et al. (2010) TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. Cancer Cell 17: 481-496.
15. Kajino-Sakamoto R, Inagaki M, Lippert E, Akira S, Robine S, et al. (2008) Enterocyte-derived TAK1 signaling prevents epithelium apoptosis and the development of ileitis and colitis. J Immunol 181: 1143-1152.
16. Morioka S, Omori E, Kajino T, Kajino-Sakamoto R, Matsumoto K, et al. (2009) TAK1 kinase determines TRAIL sensitivity by modulating reactive oxygen species and cIAP. Oncogene 28: 2257-2265.
17. Omori E, Matsumoto K, Sanjo H, Sato S, Akira S, et al. (2006) TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis. J Biol Chem 281: 19610-19617.
18. Omori E, Morioka S, Matsumoto K, Ninomiya-Tsuji J, (2008) TAK1 regulates reactive oxygen species and cell death in keratinocytes, which is essential for skin integrity. J Biol Chem 283: 26161-26168.
19. Shim JH, Xiao C, Paschal AE, Bailey ST, Rao P, et al. (2005) TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev 19: 2668-2681.
20. Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, et al. (2005) Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 6: 1087-1095.
21. Vanlangenakker N, Vanden Berghe T, Bogaert P, Laukens B, Zobel K, et al. (2011) cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production. Cell Death Differ 18: 656-665.
22. Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, et al. (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4: 313-321.
23. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, et al. (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1: 112-119.
24. Vince JE, Pantaki D, Feltham R, Mace PD, Cordier SM, et al. (2009) TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis. J Biol Chem 284: 35906-35915.
25. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, et al. (1995) Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270: 2008-2011.
26. Smith CC, Davidson SM, Lim SY, Simpkin JC, Hothersall JS, et al. (2007) Necrostatin: a potentially novel cardioprotective agent? Cardiovasc Drugs Ther 21: 227-233.
27. Stilmann M, Hinz M, Arslan SC, Zimmer A, Schreiber V, et al. (2009) A nuclear poly(ADP-ribose)-dependent signalosome confers DNA damage-induced IkappaB kinase activation. Mol Cell 36: 365-378.